Fennec Pharmaceuticals Company Executives
| FRX Stock | CAD 10.63 0.00 0.00% |
Fennec Pharmaceuticals employs about 32 people. The company is managed by 12 executives with a total tenure of roughly 31 years, averaging almost 2.0 years of service per executive, having 2.67 employees per reported executive. Analysis of Fennec Pharmaceuticals' management performance can provide insight into the firm performance.
| Rostislav Raykov CEO CEO and President and Director |
Fennec |
Fennec Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.0539) % which means that it has lost $0.0539 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (10.0559) %, meaning that it generated substantial loss on money invested by shareholders. Fennec Pharmaceuticals' management efficiency ratios could be used to measure how well Fennec Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Fennec Pharmaceuticals' Return On Capital Employed is very stable compared to the past year. As of the 29th of December 2025, Return On Equity is likely to grow to 0.08, while Return On Tangible Assets are likely to drop (0.01). At this time, Fennec Pharmaceuticals' Asset Turnover is very stable compared to the past year.As of the 29th of December 2025, Common Stock Shares Outstanding is likely to grow to about 28.7 M, while Net Loss is likely to drop (457.8 K).
Fennec Pharmaceuticals Workforce Comparison
Fennec Pharmaceuticals is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 5,013. Fennec Pharmaceuticals maintains roughly 32.0 in number of employees contributing less than 1% to equities under Health Care industry.
Fennec Pharmaceuticals Profit Margins
The company has Profit Margin (PM) of (0.18) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.02) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.02.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.89 | 0.933 |
|
|
Fennec Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Fennec Pharmaceuticals Price Series Summation is a cross summation of Fennec Pharmaceuticals price series and its benchmark/peer.
Fennec Pharmaceuticals Notable Stakeholders
A Fennec Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Fennec Pharmaceuticals often face trade-offs trying to please all of them. Fennec Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Fennec Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Rostislav Raykov | CEO and President and Director | Profile | |
| Jeffrey Hackman | CEO Director | Profile | |
| Lei Fang | President Inc | Profile | |
| Adrian Haigh | Independent Director | Profile | |
| Mark Meier | VP Commercial | Profile | |
| Christiana MBA | Chief Officer | Profile | |
| Mark Gowland | Controller | Profile | |
| Terry Evans | Chief Officer | Profile | |
| Robert Andrade | Chief Officer | Profile | |
| Dr MS | Chief Officer | Profile | |
| Anne McKay | Regulatory Consultant | Profile | |
| Alexander MS | Consultant | Profile |
About Fennec Pharmaceuticals Management Performance
The success or failure of an entity such as Fennec Pharmaceuticals often depends on how effective the management is. Fennec Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Fennec management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Fennec management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | 0.07 | 0.07 | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | 0.08 | 0.08 |
Fennec Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Fennec Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Fennec Pharmaceuticals within its industry.Fennec Pharmaceuticals Manpower Efficiency
Return on Fennec Pharmaceuticals Manpower
| Revenue Per Employee | 1.5M | |
| Revenue Per Executive | 4M | |
| Net Loss Per Employee | 13.6K | |
| Net Loss Per Executive | 36.3K | |
| Working Capital Per Employee | 1.2M | |
| Working Capital Per Executive | 3.1M |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. To learn how to invest in Fennec Stock, please use our How to Invest in Fennec Pharmaceuticals guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.